126 related articles for article (PubMed ID: 9083517)
21. Therapy-related changes of CD20+ and CD45RO+ lymphocyte subsets in chronic myeloid leukemia (CML): an immunohistochemical and morphometric study on sequential trephine biopsies of the bone marrow.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Cvetanovska G; Blum N; Schaefer HE
Mod Pathol; 2000 Aug; 13(8):888-96. PubMed ID: 10955456
[TBL] [Abstract][Full Text] [Related]
22. BCR/ABL-negative progenitors are enriched in the adherent fraction of CD34+ cells circulating in the blood of chronic phase chronic myeloid leukemia patients.
Grand FH; Marley SB; Chase A; Titley I; Healy L; Spencer A; Reiter A; Goldman JM; Gordon MY
Leukemia; 1997 Sep; 11(9):1486-92. PubMed ID: 9305602
[TBL] [Abstract][Full Text] [Related]
23. Histiocytic diseases of bone marrow.
Lee RE
Hematol Oncol Clin North Am; 1988 Dec; 2(4):657-67. PubMed ID: 3220804
[TBL] [Abstract][Full Text] [Related]
24. Evaluating the volume ratio of bone marrow affected by fibrosis: a parameter crucial for the prognostic significance of marrow fibrosis in chronic myeloid leukemia.
Buesche G; Georgii A; Duensing A; Schmeil A; Schlue J; Kreipe HH
Hum Pathol; 2003 Apr; 34(4):391-401. PubMed ID: 12733122
[TBL] [Abstract][Full Text] [Related]
25. Follow-up studies with sequential bone marrow biopsies in chronic myeloid leukaemia and so-called primary (idiopathic) osteo-myelofibrosis. Evolution of histopathological lesions and clinical course in 40 patients.
Thiele J; Simon KG; Fischer R; Zankovich R
Pathol Res Pract; 1988 Aug; 183(4):434-45. PubMed ID: 3186544
[TBL] [Abstract][Full Text] [Related]
26. Immunophenotypical comparison of Gaucher's and pseudo-Gaucher cells.
Florena AM; Franco V; Campesi G
Pathol Int; 1996 Feb; 46(2):155-60. PubMed ID: 10846564
[TBL] [Abstract][Full Text] [Related]
27. Histopathological changes in bone marrow biopsies from patients with chronic myeloid leukaemia after treatment with recombinant alpha-interferon.
Facchetti F; Tironi A; Marocolo D; Capucci A; Ruggeri G; Bellotti D; Rossi G
Histopathology; 1997 Jul; 31(1):3-11. PubMed ID: 9253618
[TBL] [Abstract][Full Text] [Related]
28. Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia - prospective long-term results from a randomized-controlled trial.
Buesche G; Hehlmann R; Hecker H; Heimpel H; Heinze B; Schmeil A; Pfirrmann M; Gomez G; Tobler A; Herrmann H; Kappler M; Hasford J; Buhr T; Kreipe HH; Georgii A
Leukemia; 2003 Dec; 17(12):2444-53. PubMed ID: 14562117
[TBL] [Abstract][Full Text] [Related]
29. Increased megakaryocytic proliferation, pro-platelet deposition and expression of fibrosis-associated factors in children with chronic myeloid leukaemia with bone marrow fibrosis.
Hussein K; Stucki-Koch A; Göhring G; Kreipe H; Suttorp M
Leukemia; 2017 Jul; 31(7):1540-1546. PubMed ID: 28239144
[TBL] [Abstract][Full Text] [Related]
30. [Cytogenetic response as a marker of efficacy of chronic myeloid leukemia therapy with a BCR-ABL thyrosine kinase inhibitor glivek].
Turkina AG; Kruglov SS; Druzhkova GA; Domracheva EV; Zakharova AV; Vinogradova OIu; Sysoeva EP; Diachenko LV; Chelysheva EIu; Zakharova ES; Abakumov EM; Kolosheĭnova TI; Kolosova LIu; Ivanova TV; Zhuravlev VS; Nemchenko IS; Zingerman BV; Kurova ES; Triputen' NZ; Loriia SS; Kovaleva LG; Khoroshko ND
Ter Arkh; 2005; 77(7):42-7. PubMed ID: 16116908
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow morphology at diagnosis as a prognostic parameter in Philadelphia-positive chronic myelogenous leukaemia (CML).
Lorand-Metze I
Br J Haematol; 1989 Jan; 71(1):163. PubMed ID: 2917124
[No Abstract] [Full Text] [Related]
32. Relationship between the type of BCR-ABL rearrangement and bone marrow histopathological features in chronic myeloid leukemia.
Colleoni GW; Silva MR; Silva RS; Costa FF; Kerbauy J; Saad ST
Acta Oncol; 1997; 36(3):313-5. PubMed ID: 9208903
[TBL] [Abstract][Full Text] [Related]
33. Therapy-related changes of CD34+ progenitor cells in chronic myeloid leukemia: a morphometric study on sequential trephine biopsies.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Goekce D; Diehl V; Zankovich R; Schaefer HE
J Hematother Stem Cell Res; 2001 Dec; 10(6):827-36. PubMed ID: 11798509
[TBL] [Abstract][Full Text] [Related]
34. Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response: meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemia.
Buesche G; Freund M; Hehlmann R; Georgii A; Ganser A; Hecker H; Heimpel H; Fonatsch C; Heinze B; Pfirrmann M; Holgado S; Schmeil A; Tobler A; Hasford J; Buhr T; Kreipe HH;
Leukemia; 2004 Sep; 18(9):1460-7. PubMed ID: 15284854
[TBL] [Abstract][Full Text] [Related]
35. Macrophages in normal human bone marrow and in chronic myeloproliferative disorders: an immunohistochemical and morphometric study by a new monoclonal antibody (PG-M1) on trephine biopsies.
Thiele J; Braeckel C; Wagner S; Falini B; Dienemann D; Stein H; Fischer R
Virchows Arch A Pathol Anat Histopathol; 1992; 421(1):33-9. PubMed ID: 1636247
[TBL] [Abstract][Full Text] [Related]
36. Detection of bcr/abl mRNA in stained bone marrow smears.
Yamashita S; Umemura T; Sadamura S; Yufu Y; Nishimura J; Nawata H
Leukemia; 1994 Aug; 8(8):1409-10. PubMed ID: 8057682
[TBL] [Abstract][Full Text] [Related]
37. Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic phase CML patients monitored by RQ-PCR for BCR-ABL.
Ross DM; Branford S; Moore S; Hughes TP
Leukemia; 2006 Apr; 20(4):664-70. PubMed ID: 16482210
[TBL] [Abstract][Full Text] [Related]
38. Efficient long-term maintenance of chronic myeloid leukemic cobblestone area forming cells on a murine stromal cell line.
Cornelissen JJ; Wognum AW; Ploemacher RE; Frassoni F; Wagemaker G; Hagemeijer A; Löwenberg B
Leukemia; 1997 Jan; 11(1):126-33. PubMed ID: 9001428
[TBL] [Abstract][Full Text] [Related]
39. [Detection of the BCR-ABL fusion: Comparative analysis of six commercially available FISH fusion probes].
Knas T; Buck M; Stegelmann F; Möller P; Barth TF
Pathologe; 2015 Jul; 36(4):372-84. PubMed ID: 26175197
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of "discordant maturation' in chronic myeloid leukaemia using cultures of primitive progenitor cells and their production of clonogenic progeny (CFU-GM).
Marley SB; Lewis JL; Scott MA; Goldman JM; Gordon MY
Br J Haematol; 1996 Nov; 95(2):299-305. PubMed ID: 8904885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
